openFDA 药品召回·· 7 天前精选AI 评分58
费森尤斯医疗召回4.25%葡萄糖腹膜透析液,因主袋可能渗漏缺乏无菌保障
DELFLEX Peritoneal Dialysis Solution with 4.25% Dextrose, Low Magnesium/ Low Calcium and Attached stay safe Exchange Set, 2,500 mL Single dose bag, Sterile and Non-Pyrogenic, Rx only, CAT.NO. 054-25324. Fresenius Medical Care, Renal Therapies Group, LLC, Lawrence, MA 01843. NDC 46163-212-94
AI 导读
openFDA 发布召回信息,费森尤斯医疗(Fresenius Medical Care)Renal Therapies Group 召回 DELFLEX 腹膜透析液(4.25% 葡萄糖、低镁/低钙,含 stay safe 交换装置,2,500 mL 单剂量袋,CAT.NO. 054-25324,NDC 46163-212-94)。
推荐理由
召回原因指向主袋印刷区小穿孔可能渗漏,读者可据此了解该批腹膜透析液的无菌保障风险。
来源:openFDA 药品召回 · api.fda.gov